Structural and dynamic differences between normal and transforming N-ras gene products: a phosphorus-31 and isotope-edited proton NMR study
- 1 November 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 28 (24) , 9478-9484
- https://doi.org/10.1021/bi00450a035
Abstract
[15N]Glycine was biosynthetically incorporated into normal cellular N-ras p21 and a position 12 transforming mutant, in order to produce p21 proteins containing several site-specific NMR probes at or near activating positions in the guanine nucleotide binding domain. We have previously assigned all five glycine resonances located in loops directly involved in binding of guanosine diphosphate in the wild-type p21 protein [Campbell-Burk, S., Papastavros, M. Z., McCormick, F., and Redfield, A. G. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 817-820]. In this report, the corresponding glycine resonances in the p21 mutant have been assigned, and spectral differences between normal and mutant p21-guanosine diphosphate (p21 .cntdot. GDP) complexes have been investigated. Our combined 1H{15N} and 31P NMR results show that substitution of aspartate for glycine-12 produces perturbations in the phosphoryl binding domain, near the point of the mutation. Although many of the remaining glycines were unaffected, spectral differences were also observed outside the GDP binding domain. Two of the five active-site glycines in wild-type p21 .cntdot. GDP have very slow amide proton exchange rates with water (k < 2.8 .times. 10-5 s-1). The active-site glycines are located in solvent-exposed loops, so their apparent solvent inaccessibility may result from strong hydrogen bond formation between glycine amide protons and bound guanine diphosphate and/or other nearby groups in p21.This publication has 21 references indexed in Scilit:
- ras GENESAnnual Review of Biochemistry, 1987
- Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutationsNature, 1983
- Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogeneNature, 1983
- A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogeneNature, 1982
- Mechanism of activation of a human oncogeneNature, 1982
- Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genesJournal of Virology, 1982
- Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene familyJournal of Virology, 1982
- The Structure of the EF‐Tu · GDP · Me2+ ComplexEuropean Journal of Biochemistry, 1982
- Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistryCell, 1980
- Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma virusesProceedings of the National Academy of Sciences, 1979